Abstract
There is accumulating evidence for auditory dysfunctions in patients with Parkinson’s disease (PD). Moreover, a possible relationship has been suggested between altered auditory intensity processing and the hypophonic speech characteristics in PD. Nonetheless, further insight into the neurophysiological correlates of auditory intensity processing in patients with PD is needed primarily. In the present study, high-density EEG recordings were used to investigate intensity dependence of auditory evoked potentials (IDAEPs) in 14 patients with PD and 14 age- and gender-matched healthy control participants (HCs). Patients with PD were evaluated in both the on- and off-medication states. HCs were also evaluated twice. Significantly increased IDAEP of the N1/P2 was demonstrated in patients with PD evaluated in the on-medication state compared to HCs. Distinctive results were found for the N1 and P2 component. Regarding the N1 component, no differences in latency or amplitude were shown between patients with PD and HCs regardless of the medication state. In contrast, increased P2 amplitude was demonstrated in patients with PD evaluated in the on-medication state compared to the off-medication state and HCs. In addition to a dopaminergic deficiency, deficits in serotonergic neurotransmission in PD were shown based on increased IDAEP. Due to specific alterations of the N1–P2 complex, the current results suggest deficiencies in early-attentive inhibitory processing of auditory input in PD. This interpretation is consistent with the involvement of the basal ganglia and the role of dopaminergic and serotonergic neurotransmission in auditory gating.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
Availability of data and materials
Data are considered confidential.
References
Adler LE, Pachtman E, Franks R, Pecevich M, Waldo M, Freedman R (1982) Neurophysiological evidence for a defect in neuronal mechanisms involved in sensory gating in schizophrenia. Biol Psychiatry 17(6):639–654
Al Jaja A, Grahn JA, Herrmann B, MacDonald PA (2020) The effect of aging, Parkinson’s disease, and exogenous dopamine on the neural response associated with auditory regularity processing. Neurobiol Aging 89:71–82. https://doi.org/10.1016/j.neurobiolaging.2020.01.002
Alain C, Tremblay K (2007) The role of event-related brain potentials in assessing central auditory processing. J Am Acad Audiol 18(7):573–589. https://doi.org/10.3766/jaaa.18.7.5
Alain C, McDonald KL, Ostroff JM (2004) Aging: a switch from automatic to controlled processing of sounds? Psychol Aging 19(1):125–133
Amenedo E, Diaz F (1998) Aging-related changes in processing of non-target and target stimuli during an auditory oddball task. Biol Psychol 48(3):235–267. https://doi.org/10.1016/s0301-0511(98)00040-4
Anderer P, Semlitsch HV, Saletu B (1996) Multichannel auditory event-related brain potentials: effects of normal aging on the scalp distribution of N1, P2, N2 and P300 latencies and amplitudes. Electroencephalogr Clin Neurophysiol 99(5):458–472. https://doi.org/10.1016/s0013-4694(96)96518-9
Annanmaki T, Palmu K, Murros K, Partanen J (2017) Altered N100-potential associates with working memory impairment in Parkinson’s disease. J Neural Transm (Vienna, Austria: 1996) 124(10):1197–1203. https://doi.org/10.1007/s00702-017-1758-z
Arnott SR, Bardouille T, Ross B, Alain C (2011) Neural generators underlying concurrent sound segregation. Brain Res 1387:116–124. https://doi.org/10.1016/j.brainres.2011.02.062
Barone P (2010) Neurotransmission in Parkinson’s disease: beyond dopamine. Eur J Neurol 17(3):364–376. https://doi.org/10.1111/j.1468-1331.2009.02900.x
Bartels AL, Leenders KL (2009) Parkinson’s disease: the syndrome, the pathogenesis and pathophysiology. Cortex 45(8):915–921. https://doi.org/10.1016/j.cortex.2008.11.010
Beauducel A, Debener S, Brocke B, Kayser J (2000) On the reliability of augmenting/reducing—peak amplitudes and principal component analysis of auditory evoked potentials. J Psychophysiol 14(4):226–240. https://doi.org/10.1027//0269-8803.14.4.226
Beck AT, Ward CH, Mendelson M, Mock J, Erbaugh J (1961) An inventory for measuring depression. Arch Gen Psychiatry 4:561–571. https://doi.org/10.1001/archpsyc.1961.01710120031004
Beck AT, Steer RA, Brown GK (1996) Manual for the Beck depression inventory–II. Psychological Corporation, San Antonio, TX
Beucke JC, Uhl I, Plotkin M, Winter C, Assion HJ, Endrass T, Amthauer H, Kupsch A, Juckel G (2010) Serotonergic neurotransmission in early Parkinson’s disease: a pilot study to assess implications for depression in this disorder. World J Biol Psychiatry 11(6):781–787. https://doi.org/10.3109/15622975.2010.491127
Boecker H, Ceballos-Baumann A, Bartenstein P, Weindl A, Siebner HR, Fassbender T, Munz F, Schwaiger M, Conrad B (1999) Sensory processing in Parkinson’s and Huntington’s disease: investigations with 3D H(2)(15)O-PET. Brain 122:1651–1665. https://doi.org/10.1093/brain/122.9.1651
Boutros NN, Belger A, Campbell D, D’Souza C, Krystal J (1999) Comparison of four components of sensory gating in schizophrenia and normal subjects: a preliminary report. Psychiatry Res 88(2):119–130. https://doi.org/10.1016/s0165-1781(99)00074-8
Braak H, Del Tredici K, Rüb U, de Vos RA, Jansen Steur EN, Braak E (2003) Staging of brain pathology related to sporadic Parkinson’s disease. Neurobiol Aging 24(2):197–211. https://doi.org/10.1016/s0197-4580(02)00065-9
Chaudhuri KR, Healy DG, Schapira AHV (2006) Non-motor symptoms of Parkinson’s disease: diagnosis and management. Lancet Neurol 5(3):235–245. https://doi.org/10.1016/s1474-4422(06)70373-8
Clark JP, Adams SG, Dykstra AD, Moodie S, Jog M (2014) Loudness perception and speech intensity control in Parkinson’s disease. J Commun Disord 51:1–12. https://doi.org/10.1016/j.jcomdis.2014.08.001
Cools R (2006) Dopaminergic modulation of cognitive function-implications for L-DOPA treatment in Parkinson’s disease. Neurosci Biobehav Rev 30(1):1–23. https://doi.org/10.1016/j.neubiorev.2005.03.024
Crowley KE, Colrain IM (2004) A review of the evidence for P2 being an independent component process: age, sleep and modality. Clin Neurophysiol 115(4):732–744. https://doi.org/10.1016/j.clinph.2003.11.021
Darley FL, Aronson AE, Brown JR (1969) Differential diagnostic patterns of dysarthria. J Speech Hear Res 12(2):246–269. https://doi.org/10.1044/jshr.1202.246
Daw ND, Kakade S, Dayan P (2002) Opponent interactions between serotonin and dopamine. Neural Netw 15(4–6):603–616. https://doi.org/10.1016/s0893-6080(02)00052-7
De Groote E, De Keyser K, Bockstael A, Botteldooren D, Santens P, De Letter M (2020) Central auditory processing in parkinsonian disorders: a systematic review. Neurosci Biobehav Rev 113:111–132. https://doi.org/10.1016/j.neubiorev.2020.03.001
De Keyser K, De Letter M, De Groote E, Santens P, Talsma D, Botteldooren D, Bockstael A (2019) Systematic audiological assessment of auditory functioning in patients with Parkinson’s disease. J Speech Lang Hear Res 62(12):4564–4577. https://doi.org/10.1044/2019_jslhr-h-19-0097
De Keyser K, Santens P, Bockstael A, Botteldooren D, Talsma D, De Vos S, Van Cauwenberghe M, Verheugen F, Corthals P, De Letter M (2016) The relationship between speech production and speech perception deficits in Parkinson’s disease. J Speech Lang Hear Res 59(5):915–931. https://doi.org/10.1044/2016_JSLHR-S-15-0197
Defer GL, Widner H, Marie RM, Remy P, Levivier M (1999) Core assessment program for surgical interventional therapies in Parkinson’s disease (CAPSIT-PD). Mov Disord 14(4):572–584. https://doi.org/10.1002/1531-8257(199907)14:4%3c572::aid-mds1005%3e3.0.co;2-c
Dubbioso R, Manganelli F, Siebner HR, Di Lazzaro V (2019) Fast intracortical sensory-motor integration: a window into the pathophysiology of Parkinson’s disease. Front Hum Neurosci 13:111. https://doi.org/10.3389/fnhum.2019.00111
Duffy JR (2005) Motor speech disorders: Substrates, differential diagnosis, and management. 2nd edn. St. Louis, Mo: Elsevier Mosby
Duncan CC, Barry RJ, Connolly JF, Fischer C, Michie PT, Näätänen R, Polich J, Reinvang I, Van Petten C (2009) Event-related potentials in clinical research: guidelines for eliciting, recording, and quantifying mismatch negativity, P300, and N400. Clin Neurophysiol 120(11):1883–1908
Dushanova J (2011) Brain event-related oscillations in Parkinsonian patients during discrimination task conditions. In: Dushanova J (ed) Diagnostics and rehabilitation of Parkinson’s disease. InTech, Rijeka, pp 59–85
Dushanova J, Philipova D, Nikolova G (2009) Event-related desynchronization/synchronization during discrimination task conditions in patients with Parkinson’s disease. Cell Mol Neurobiol 29(6–7):971–980
Dushanova J, Philipova D, Nikolova G (2010) Beta and gamma frequency-range abnormalities in parkinsonian patients under cognitive sensorimotor task. J Neurol Sci 293(1–2):51–58
Freedman R, Waldo M, Bickford-Wimer P, Nagamoto H (1991) Elementary neuronal dysfunction in schizophrenia. Schizophr Res 4:233–243
Fritz JB, Elhilali M, David SV, Shamma SA (2007) Auditory attention–focusing the searchlight on sound. Curr Opin Neurobiol 17(4):437–455. https://doi.org/10.1016/j.conb.2007.07.011
Garcia-Larrea L, Lukaszewicz AC, Mauguiere F (1992) Revisiting the oddball paradigm. Non-target vs neutral stimuli and the evaluation of ERP attentional effects. Neuropsychologia 30(8):723–741. https://doi.org/10.1016/0028-3932(92)90042-k
Georgiev D, Jahanshahi M, Dreo J, Cus A, Pirtosek Z, Repovs G (2015) Dopaminergic medication alters auditory distractor processing in Parkinson’s disease. Acta Physiol (Oxf) 156:45–56. https://doi.org/10.1016/j.actpsy.2015.02.001
Getzmann S, Lewald J, Falkenstein M (2014) Using auditory pre-information to solve the cocktail-party problem: electrophysiological evidence for age-specific differences. Front Neurosci 8:413. https://doi.org/10.3389/fnins.2014.00413
Goetz CG, Poewe W, Rascol O, Sampaio C, Stebbins GT, Counsell C, Giladi N, Holloway RG, Moore CG, Wenning GK, Yahr MD, Seidl L, Movement Disorder Society Task Force on Rating Scales for Parkinson’s D (2004) Movement Disorder Society Task Force report on the Hoehn and Yahr staging scale: status and recommendations. Movement 19(9):1020–1028. https://doi.org/10.1002/mds.20213
Goetz CG, Fahn S, Martinez-Martin P, Poewe W, Sampaio C, Stebbins GT, Stern MB, Tilley BC, Dodel R, Dubois B, Holloway R, Jankovic J, Kulisevsky J, Lang AE, Lees A, Leurgans S, LeWitt PA, Nyenhuis D, Olanow CW, Rascol O, Schrag A, Teresi JA, Van Hilten JJ, LaPelle N (2007) Movement Disorder Society-sponsored revision of the Unified Parkinson’s Disease Rating Scale (MDS-UPDRS): process, format, and clinimetric testing plan. Mov Disord 22(1):41–47. https://doi.org/10.1002/mds.21198
Golubic SJ, Jurasic MJ, Susac A, Huonker R, Gotz T, Haueisen J (2019) Attention modulates topology and dynamics of auditory sensory gating. Hum Brain Mapp 40(10):2981–2994. https://doi.org/10.1002/hbm.24573
Gopal KV, Daly DM, Daniloff RG, Pennartz L (2000) Effects of selective serotonin reuptake inhibitors on auditory processing: case study. J Am Acad Audiol 11(8):454–463
Güdücü Ç, Eskicioğlu E, Öz D, Öniz A, Çakmur R, Özgören M (2019) Auditory brain oscillatory responses in drug-naïve patients with Parkinson’s disease. Neurosci Lett 701:170–174
Guiard BP, El Mansari M, Merali Z, Blier P (2008) Functional interactions between dopamine, serotonin and norepinephrine neurons: an in-vivo electrophysiological study in rats with monoaminergic lesions. Int J Neuropsychopharmacol 11(5):625–639. https://doi.org/10.1017/S1461145707008383
Gulberti A, Hamel W, Buhmann C, Boelmans K, Zittel S, Gerloff C, Westphal M, Engel AK, Schneider TR, Moll CK (2015) Subthalamic deep brain stimulation improves auditory sensory gating deficit in Parkinson’s disease. Clin Neurophysiol 126(3):565–574. https://doi.org/10.1016/j.clinph.2014.06.046
Güntekin B, Hanoğlu L, Güner D, Yılmaz NH, Çadırcı F, Mantar N, Aktürk T, Emek-Savaş DD, Özer FF, Yener G, Başar E (2018) Cognitive impairment in parkinson’s disease is reflected with gradual decrease of EEG delta responses during auditory discrimination. Front Psychol 9:170
Hall IC, Sell GL, Hurley LM (2011) Social regulation of serotonin in the auditory midbrain. Behav Neurosci 125(4):501–511. https://doi.org/10.1037/a0024426
Hari R, Pelizzone M, Makela JP, Hallstrom J, Leinonen L, Lounasmaa OV (1987) Neuromagnetic responses of the human auditory cortex to on- and offsets of noise bursts. Audiology 26(1):31–43. https://doi.org/10.3109/00206098709078405
Harris KC, Mills JH, Dubno JR (2007) Electrophysiologic correlates of intensity discrimination in cortical evoked potentials of younger and older adults. Hear Res 228(1–2):58–68. https://doi.org/10.1016/j.heares.2007.01.021
Hegerl U, Juckel G (1993) Intensity dependence of auditory evoked-potentials as an indicator of central serotonergic neurotransmission—a new hypothesis. Biol Psychiatry 33(3):173–187. https://doi.org/10.1016/0006-3223(93)90137-3
Hegerl U, Gallinat J, Juckel G (2001) Event-related potentials: do they reflect central serotonergic neurotransmission and do they predict clinical response to serotonin agonists? J Affect Disord 62(1–2):93–100. https://doi.org/10.1016/s0165-0327(00)00353-0
Hensch T, Herold U, Diers K, Armbruster D, Brocke B (2008) Reliability of intensity dependence of auditory-evoked potentials. Clin Neurophysiol 119(1):224–236. https://doi.org/10.1016/j.clinph.2007.09.127
Ho AK, Bradshaw JL, Iansek T (2000) Volume perception in parkinsonian speech. Mov Disord 15(6):1125–1131. https://doi.org/10.1002/1531-8257(200011)15:6%3c1125::aid-mds1010%3e3.0.co;2-r
Hoehn MM, Yahr MD (1967) Parkinsonism: onset, progression and mortality. Neurology 17(5):427–442. https://doi.org/10.1212/wnl.17.5.427
Hurley LM, Hall IC (2011) Context-dependent modulation of auditory processing by serotonin. Hear Res 279(1–2):74–84. https://doi.org/10.1016/j.heares.2010.12.015
Jafari Z, Kolb BE, Mohajerani MH (2020) Auditory dysfunction in Parkinson’s disease. Mov Disord. https://doi.org/10.1002/mds.28000
Jankovic J (2008) Parkinson’s disease: clinical features and diagnosis. J Neurol Neurosurg Psychiatry 79(4):368–376. https://doi.org/10.1136/jnnp.2007.131045
Jastreboff PJ, Jastreboff MM (2015) Decreased sound tolerance: hyperacusis, misophonia, diplacousis, and polyacousis. Handb Clin Neurol 129:375–387. https://doi.org/10.1016/b978-0-444-62630-1.00021-4
Juckel G, Hegerl U, Molnar M, Csepe V, Karmos G (1999) Auditory evoked potentials reflect serotonergic neuronal activity—a study in behaving cats administered drugs acting on 5-HT1A autoreceptors in the dorsal raphe nucleus. Neuropsychopharmacology 21(6):710–716. https://doi.org/10.1016/S0893-133X(99)00074-3
Juckel G, Gallinat J, Riedel M, Sokullu S, Schulz C, Möller H-J, Müller N, Hegerl U (2003) Serotonergic dysfunction in schizophrenia assessed by the loudness dependence measure of primary auditory cortex evoked activity. Schizophr Res 64(2–3):115–124. https://doi.org/10.1016/s0920-9964(03)00016-1
Juckel G, Hegerl U, Giegling I, Mavrogiorgou P, Wutzler A, Schuhmacher C, Uhl I, Brune M, Mulert C, Pogarell O, Rujescu D (2008) Association of 5-HT1B receptor polymorphisms with the loudness dependence of auditory evoked potentials in a community-based sample of healthy volunteers. Am J Med Genet 147B(4):454–458. https://doi.org/10.1002/ajmg.b.30628
Kaji R, Urushihara R, Murase N, Shimazu H, Goto S (2005) Abnormal sensory gating in basal ganglia disorders. J Neurol 252(Suppl 4):13–16. https://doi.org/10.1007/s00415-005-4004-9
Kamarajan C, Pandey AK, Chorlian DB, Porjesz B (2015) The use of current source density as electrophysiological correlates in neuropsychiatric disorders: a review of human studies. Int J Psychophysiol 97(3):310–322. https://doi.org/10.1016/j.ijpsycho.2014.10.013
Kappenman ES, Luck SJ (2012) The Oxford handbook of event-related potential components. New York: Oxford University Press. doi:https://doi.org/10.1093/oxfordhb/9780195374148.001.0001
Kapur S, Remington G (1996) Serotonin-dopamine interaction and its relevance to schizophrenia. Am J Psychiatry 153(4):466–476. https://doi.org/10.1176/ajp.153.4.466
Keesom SM, Hurley LM (2020) Silence, solitude, and serotonin: Neural mechanisms linking hearing loss and social isolation. Brain Sci 10(6):367
Kwan LC, Whitehill TL (2011) Perception of speech by individuals with Parkinson’s disease: a review. Parkinson’s Dis 2011:389767. https://doi.org/10.4061/2011/389767
Lee AC, Godfrey DA (2014) Cochlear damage affects neurotransmitter chemistry in the central auditory system. Front Neurol 5:227
Li Y, Li C-Y, Xi W, Jin S, Wu Z-H, Jiang P, Dong P, He X-B, Xu F-Q, Duan S, Zhou Y-D, Li X-M (2019) Rostral and caudal ventral tegmental area GABAergic inputs to different dorsal raphe neurons participate in opioid dependence. Neuron 101(4):748-761.e745. https://doi.org/10.1016/j.neuron.2018.12.012
Lidsky TI, Manetto C, Schneider JS (1985) A consideration of sensory factors involved in motor functions of the basal ganglia. Brain Res 356(2):133–146. https://doi.org/10.1016/0165-0173(85)90010-4
Lightfoot G (2016) Summary of the N1–P2 cortical auditory evoked potential to estimate the auditory threshold in adults. Semin Hear 37(1):1–8. https://doi.org/10.1055/s-0035-1570334
Lijffijt M, Lane SD, Meier SL, Boutros NN, Burroughs S, Steinberg JL, Moeller FG, Swann AC (2009) P50, N100, and P200 sensory gating: relationships with behavioral inhibition, attention, and working memory. Psychophysiology 46(5):1059–1068
Luck SJ (2014) An introduction to the event-related potential technique, 2nd edn. MIT Press, Cambridge
Lukhanina EP, Kapustina MT, Berezetskaya NM, Karaban IN (2009) Reduction of the postexcitatory cortical inhibition upon paired-click auditory stimulation in patients with Parkinson’s disease. Clin Neurophysiol 120(10):1852–1858. https://doi.org/10.1016/j.clinph.2009.07.040
Lukhanina E, Berezetskaya N, Karaban I (2010) Paired-pulse inhibition in the auditory cortex in Parkinson’s disease and its dependence on clinical characteristics of the patients. Parkinson’s Dis 2011:342151. https://doi.org/10.4061/2011/342151
MacDonald PA, Monchi O (2011) Differential effects of dopaminergic therapies on dorsal and ventral striatum in Parkinson’s disease: implications for cognitive function. Parkinson’s Dis 2011:572743. https://doi.org/10.4061/2011/572743
Mayer AR, Hanlon FM, Franco AR, Teshiba TM, Thoma RJ, Clark VP, Canive JM (2009) The neural networks underlying auditory sensory gating. Neuroimage 44(1):182–189. https://doi.org/10.1016/j.neuroimage.2008.08.025
Millan MJ, Dekeyne A, Gobert A (1998) Serotonin (5-HT)2C receptors tonically inhibit dopamine (DA) and noradrenaline (NA), but not 5-HT, release in the frontal cortex in vivo. Neuropharmacology 37(7):953–955. https://doi.org/10.1016/s0028-3908(98)00078-1
Mulert C, Jager L, Propp S, Karch S, Stormann S, Pogarell O, Moller HJ, Juckel G, Hegerl U (2005) Sound level dependence of the primary auditory cortex: simultaneous measurement with 61-channel EEG and fMRI. Neuroimage 28(1):49–58. https://doi.org/10.1016/j.neuroimage.2005.05.041
Nasreddine ZS, Phillips NA, Bedirian V, Charbonneau S, Whitehead V, Collin I, Cummings JL, Chertkow H (2005) The Montreal Cognitive Assessment, MoCA: a brief screening tool for mild cognitive impairment. J Am Geriatr Soc 53(4):695–699. https://doi.org/10.1111/j.1532-5415.2005.53221.x
O’Neill BV, Croft RJ, Leung S, Guille V, Galloway M, Phan KL, Nathan PJ (2006) Dopamine receptor stimulation does not modulate the loudness dependence of the auditory evoked potential in humans. Psychopharmacology 188(1):92–99. https://doi.org/10.1007/s00213-006-0501-5
Oestreicher E, Wolfgang A, Felix D (2002) Neurotransmission of the cochlear inner hair cell synapse–implications for inner ear therapy. Adv Otorhinolaryngol 59:131–139
Paiva TO, Almeida PR, Ferreira-Santos F, Vieira JB, Silveira C, Chaves PL, Barbosa F, Marques-Teixeira J (2016) Similar sound intensity dependence of the N1 and P2 components of the auditory ERP: averaged and single trial evidence. Clin Neurophysiol 127(1):499–508. https://doi.org/10.1016/j.clinph.2015.06.016
Park A, Stacy M (2009) Non-motor symptoms in Parkinson’s disease. J Neurol 256(Suppl 3):293–298. https://doi.org/10.1007/s00415-009-5240-1
Park HK, Lee JJ, Park YM (2020) Preserved serotonergic activity in early-onset Parkinson’s disease. Can J Neurol Sci 47(3):344–349. https://doi.org/10.1017/cjn.2019.322
Perrin F, Pernier J, Bertrand O, Echallier JF (1989) Spherical splines for scalp potential and current density mapping. Electroencephalogr Clin Neurophysiol 72(2):184–187. https://doi.org/10.1016/0013-4694(89)90180-6
Picton TW, Hillyard SA, Galambos R, Schiff M (1971) Human auditory attention: a central or peripheral process? Science 173(3994):351–353
Rietdijk CD, Perez-Pardo P, Garssen J, van Wezel RJ, Kraneveld AD (2017) Exploring Braak’s Hypothesis of Parkinson’s disease. Front Neurol 8:37. https://doi.org/10.3389/fneur.2017.00037
Rosburg T, Trautner P, Elger CE, Kurthen M (2009) Attention effects on sensory gating–intracranial and scalp recordings. Neuroimage 48(3):554–563. https://doi.org/10.1016/j.neuroimage.2009.06.063
Ruel J, Wang J, Rebillard G, Eybalin M, Lloyd R, Pujol R, Puel JL (2007) Physiology, pharmacology and plasticity at the inner hair cell synaptic complex. Hear Res 227(1–2):19–27
Sapir S (2014) Multiple factors are involved in the dysarthria associated with Parkinson’s disease: a review with implications for clinical practice and research. J Speech Lang Hear Res 57(4):1330–1343. https://doi.org/10.1044/2014_JSLHR-S-13-0039
Schwent VL, Hillyard SA, Galambos R (1976a) Selective attention and the auditory vertex potential. I. Effects of stimulus delivery rate. Electroencephalogr Clin Neurophysiol 40(6):604–614
Schwent VL, Hillyard SA, Galambos R (1976b) Selective attention and the auditory vertex potential. II. Effects of signal intensity and masking noise. Electroencephalogr Clin Neurophysiol 40(6):615–622
Seo D, Patrick CJ, Kennealy PJ (2008) Role of serotonin and dopamine system interactions in the neurobiology of impulsive aggression and its comorbidity with other clinical disorders. Aggress Violent Behav 13(5):383–395. https://doi.org/10.1016/j.avb.2008.06.003
Shinn-Cunningham B (2017) Cortical and sensory causes of individual differences in selective attention ability among listeners with normal hearing thresholds. J Speech Lang Hear Res 60(10):2976–2988. https://doi.org/10.1044/2017_JSLHR-H-17-0080
Smarr KL (2003) Measures of depression and depressive symptoms: The Beck Depression Inventory (BDI), Center for Epidemiological Studies-Depression Scale (CES-D), Geriatric Depression Scale (GDS), Hospital Anxiety and Depression Scale (HADS), and Primary Care Evaluation of Mental Disorders-Mood Module (PRIME-MD). Arthritis Rheum 49(S5):S134–S146. https://doi.org/10.1002/art.11410
Solís-Vivanco R, Rodríguez-Violante M, Cervantes-Arriaga A, Justo-Guillén E, Ricardo-Garcell J (2018) Brain oscillations reveal impaired novelty detection from early stages of Parkinson’s disease. NeuroImage Clin 18:923–931
Talsma D, Senkowski D, Soto-Faraco S, Woldorff MG (2010) The multifaceted interplay between attention and multisensory integration. Trends Cogn Sci 14(9):400–410
Teo C, Rasco L, Al-Mefty K, Skinner RD, Boop FA, Garcia-Rill E (1997) Decreased habituation of midlatency auditory evoked responses in Parkinson’s disease. Mov Disord 12(5):655–664. https://doi.org/10.1002/mds.870120506
Teo C, Rasco L, Skinner RD, Garcia-Rill E (1998) Disinhibition of the sleep state-dependent P1 potential in Parkinson’s disease-improvement after pallidotomy. Sleep Res Online 1(1):62–70
Thwaites SJ, Gogos A, Van den Buuse M (2013) Schizophrenia-like disruptions of sensory gating by serotonin receptor stimulation in rats: effect of MDMA, DOI and 8-OH-DPAT. Pharmacol Biochem Behav 112:71–77. https://doi.org/10.1016/j.pbb.2013.09.016
Tomlinson CL, Stowe R, Patel S, Rick C, Gray R, Clarke CE (2010) Systematic review of levodopa dose equivalency reporting in Parkinson’s disease. Mov Disord 25(15):2649–2653. https://doi.org/10.1002/mds.23429
Venables PH (1964) Input dysfunction in schizophrenia. Prog Exp Pers Res 72:1–47
Wang HL, Zhang S, Qi J, Wang H, Cachope R, Mejias-Aponte CA, Gomez JA, Mateo-Semidey GE, Beaudoin GMJ, Paladini CA, Cheer JF, Morales M (2019) Dorsal raphe dual serotonin-glutamate neurons drive reward by establishing excitatory synapses on VTA Mesoaccumbens dopamine neurons. Cell Rep 26(5):1128-1142.e1127. https://doi.org/10.1016/j.celrep.2019.01.014
Watabe-Uchida M, Zhu L, Ogawa Sachie K, Vamanrao A, Uchida N (2012) Whole-brain mapping of direct inputs to midbrain dopamine neurons. Neuron 74(5):858–873. https://doi.org/10.1016/j.neuron.2012.03.017
Woldorff MG, Gallen CC, Hampson SA, Hillyard SA, Pantev C, Sobel D, Bloom FE (1993) Modulation of early sensory processing in human auditory cortex during auditory selective attention. Proc Natl Acad Sci USA 90(18):8722–8726. https://doi.org/10.1073/pnas.90.18.8722
Zhang Z (2019) Spectral and time-frequency analysis. EEG signal processing and feature extraction. Springer, Singapore, pp 89–116
Acknowledgements
This work was supported by a PhD fellowship grant of the Research Foundation—Flanders (FWO) awarded to KDK. PS is a senior clinical investigator at the Research Foundation—Flanders (FWO). The funding source had no role in study design, data analysis, data interpretation, or writing of the report.
Author information
Authors and Affiliations
Contributions
Conceptualization: KDK, MDL, PS, DT, DB, AB; method: KDK, MDL, PS, DT, DB, AB; formal analysis and investigation: KDK; data interpretation: KDK, MDL, PS, DT, DB, AB; writing—original draft preparation: KDK; writing—review and editing: KDK, MDL, PS, DT, AB; funding acquisition: KDK, MDL, PS, AB; resources: MDL, PS, AB; supervision: MDL, AB.
Corresponding author
Ethics declarations
Conflict of interest
None.
Ethical approval
The study was performed in accordance with the Declaration of Helsinki.
Informed consent
All participants signed a written informed consent approved by the Ethics Committee of the Ghent University Hospital.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
De Keyser, K., De Letter, M., Santens, P. et al. Neurophysiological investigation of auditory intensity dependence in patients with Parkinson’s disease. J Neural Transm 128, 345–356 (2021). https://doi.org/10.1007/s00702-021-02305-3
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00702-021-02305-3